National Science Foundation
Mid-Career Advancement
Application deadline: February 7, 2022
National Institutes of Health
Risk and Protective Factors of Family Health and Family Level Interventions (R01 – Clinical Trial Optional)
(PAR-21-358)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Office of Research on Women’s Health
Application Receipt Date(s): Multiple dates, see announcement.
HEAL Initiative: Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R01- Clinical Trial Not Allowed)
(RFA-DA-22-044)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): March 10, 2022
HEAL Initiative: Exploratory Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R21- Clinical Trial Not Allowed)
(RFA-DA-22-045)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): March 10, 2022
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
(PAS-22-096)
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute
National Institute on Aging
Application Receipt Date(s): January 07, 2025
Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)
(RFA-AG-23-003)
National Institute on Aging
Application Receipt Date(s): March 03, 2022
HEAL Initiative: Planning Grants for Efficacy or Effectiveness Trials of Recovery Support Services for Individuals Treated with Medications for Opioid Use Disorder (R34 Clinical Trial Optional)
(RFA-DA-22-034)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): March 10, 2022
HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders: Coordination Center (R24 Clinical Trial Optional)
(RFA-DA-22-042)
National Institute on Drug Abuse
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): March 10, 2022
HEAL Initiative: Research Networks for the Study of Recovery Support Services for Persons Treated with Medications for Opioid Use Disorder (R24 Clinical Trial Optional)
(RFA-DA-22-043)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): March 10, 2022
HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders (R01 Clinical Trial Optional)
(RFA-DA-22-046)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): March 10, 2022
HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01 Clinical Trial Optional)
(RFA-DA-22-047)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): March 10, 2022
HEAL Initiative: Pilot and Feasibility Trials to Improve Prevention and Treatment Service Delivery for Polysubstance Use (R34 Clinical Trial Optional)
(RFA-DA-22-048)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): March 10, 2022
HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required)
(RFA-NS-22-037)
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
Office of Research on Women’s Health
Application Receipt Date(s): March 22, 2022
Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 Clinical Trial Optional)
(RFA-MD-22-007)
National Institute on Minority Health and Health Disparities
National Institute of Mental Health
Office of Disease Prevention
Application Receipt Date(s): March 28, 2022
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
(RFA-MD-22-003)
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
Application Receipt Date(s): April 04, 2022
Innovations for Healthy Living – Improving Minority Health and Eliminating Health Disparities (R43/R44 – Clinical Trial Optional)
(RFA-MD-22-004)
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
National Institute on Drug Abuse
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
Application Receipt Date(s): April 04, 2022
Community Engaged Research on Pregnancy Related and Associated Infections and Sepsis Morbidity and Mortality (UG3/UH3 Clinical Trial Optional)
(RFA-HD-22-024)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women’s Health
Application Receipt Date(s): April 18, 2022
Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional)
(RFA-MH-22-170)
National Institute of Mental Health
National Institute on Drug Abuse
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): May 10, 2022
Advancing communication strategies to support future HIV vaccine use (R21 Clinical Trial Optional)
(RFA-MH-22-171)
National Institute of Mental Health
National Institute on Drug Abuse
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): May 10, 2022
Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)
(RFA-TR-22-013)
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): May 22, 2023
Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional)
(RFA-ES-22-002)
National Institute of Environmental Health Sciences
Application Receipt Date(s): June 09, 2022
Lipids in Brain Aging and Alzheimer’s Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed)
(RFA-AG-23-009)
National Institute on Aging
Application Receipt Date(s): June 14, 2022
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
(RFA-MH-22-135)
National Institute of Mental Health
National Institute on Aging
Application Receipt Date(s): October 15, 2022
Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
(RFA-MH-22-136)
National Institute of Mental Health
National Institute on Aging
Application Receipt Date(s): October 15, 2022
Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)
(PAR-22-057)
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke
Office of Research on Women’s Health
Application Receipt Date(s): May 01, 2023
Genome Research Experiences to Attract Talented Undergraduates into Genomic Fields to Enhance Diversity (R25 Clinical Trial Not Allowed)
(RFA-HG-22-004)
National Human Genome Research Institute
Application Receipt Date(s): July 01, 2023
Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R01 Clinical Trial Optional)
(PAR-22-093)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): November 12, 2024
Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R21 Clinical Trial Optional)
(PAR-22-094)
National Institute on Aging
Application Receipt Date(s): November 12, 2024
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
(PAR-22-060)
National Institute of Dental and Craniofacial Research
National Center for Complementary and Integrative Health
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): January 07, 2025
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
(RFA-NS-22-034)
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Multiple dates, see announcement.
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
(PAR-21-357)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Application Receipt Date(s): Multiple dates, see announcement.
(PAR-21-359)
National Institute on Aging
Application Receipt Date(s): Multiple dates, see announcement.
Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)
(PAR-21-360)
National Institute on Aging
Application Receipt Date(s): Multiple dates, see announcement.
Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 – Clinical Trials Optional)
(PAR-22-092)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Eye Institute
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Nursing Research
Office of Research on Women’s Health
Application Receipt Date(s): Multiple dates, see announcement.